Stock A208340 PHARMABCINE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart PharmAbcine Inc.

Equities

A208340

KR7208340000

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 18/01/2024 GMT 		5-day change 1st Jan Change
2,915 KRW -8.91% Intraday chart for PharmAbcine Inc. -.--% -22.27%
01-24 PharmAbcine Inc. Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA®? (Pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors CI
2023 PharmAbcine Inc. announced that it has received KRW 5.000000492 billion in funding CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PHARMABCINE INC. Stock PharmAbcine Inc.
 63.64M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. A208340 Stock
  4. Charts PharmAbcine Inc.
  5. Sector Chart